Entries by Marisa de la Cruz

Andrew Mendiola – Awarded K99

Andrew Mendiola, received a K99 award from the National Institute of Neurological Disorders and Stroke for his project “Epigenomic regulation of oxidative stress-producing innate immunity in neuroinflammation.” The purpose of the NIH Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree […]

Katerina Akassoglou: ABC 7 Interview (COVID-19)

Gladstone Institutes Senior investigator, Professor Katerina Akassoglou explains how this damage could be happening. (Full Article) “Even patients who are asymptomatic or they have very mild infection symptoms can still develop neurological symptoms,” said Katerina Akassoglou, PhD, UCSF Prof. at Dept. Neurology & Senior Investigator t the Gladstone Institutes.

Reshmi Tognatta – Awarded AARF Fellowship

Reshmi Tognatta,PhD, has been awarded the AARF for her project “Oligodendroglial- Vascular Interactions in Alzheimer’s Disease.” The Alzheimer’s Association Research Fellowship award is intended to support exceptional researchers who are engaged in their post-graduate work (i.e. postdoctoral fellows) and before they have their first independent faculty positions (i.e. Assistant Professor) and working in diverse areas […]

Katerina Akassoglou elected lifetime AAAS Fellow

Katerina Akassoglou, PhD, has been elected into the American Association for the Advancement of Science (AAAS), a lifetime distinction by the world’s largest general scientific society. “I’m grateful to my lab members and collaborators for their immeasurable contributions to these studies over the past 20 years. Election to AAAS further encourages us to follow our curiosity […]

Katerina Akassoglou Elected to National Academy of Inventors

Katerina Akassoglou, PhD, senior investigator at Gladstone Institutes, has been named a fellow of the National Academy of Inventors (NAI). Election to NAI is the highest professional distinction given solely to academic inventors. “Election to the NAI further encourages us to pursue challenging problems in biology and medicine to develop urgently needed treatments for devastating human diseases.”

Brain Selected Our Image For The August 2021 Volume

The Akassoglou Lab showed toxic blood leaks in the brain inhibiting remyelination with implications for the development of therapeutic strategies for neuro-repair in multiple sclerosis and other neurological diseases with blood-brain barrier disruption and myelin damage. From Petersen et al. BMP receptor blockade overcomes extrinsic inhibition of remyelination and restores neurovascular homeostasis. Pp. 2291-2301.